new weight loss drug semaglutide What's in Obesity Treatment? Key lawmaker wants CT to

It binds to glycine receptors in the spinal cord and brainstem, producing calming effects

doi: 10.1161/CIRCHEARTFAILURE.112.000281 218 WenL.LinX.HuD.LiJ.XieK.LiS.et al

Wegovy, another brand name formulation of semaglutide, is FDA-approved for weight management in obese individuals with a body mass index (BMI) over 30 or overweight individuals with a BMI over 27, and at least one weight-related health condition, including high cholesterol, Type 2 diabetes, and high blood pressure

(ii) Cu 2+ induces the secretion of acidic SMase from leukocytes which in turn leads to accumulation of erythrocytic ceramide [131] and (iii) treatment of erythrocytes with extracellular SMase resulted in ceramide-associated alterations in membrane-cytoskeleton interactions and membrane organization [125]